This Review discusses the manufacturing of cell products for clinically advanced cell therapies, and highlights potential manufacturing bottlenecks and solutions towards the cost-effective commercialization of the therapies.
- Ayesha Aijaz
- Matthew Li
- Biju Parekkadan